Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
22.86
+0.29 (1.28%)
At close: Oct 16, 2025, 4:00 PM EDT
24.00
+1.14 (4.99%)
Pre-market: Oct 17, 2025, 4:58 AM EDT
Centessa Pharmaceuticals Market Cap
Centessa Pharmaceuticals has a market cap or net worth of $3.06 billion as of October 17, 2025. Its market cap has increased by 38.60% in one year.
Market Cap
3.06B
Enterprise Value
2.93B
1-Year Change
38.60%
Ranking
Category
Stock Price
$22.86
Market Cap Chart
Since the IPO on May 28, 2021, Centessa Pharmaceuticals's market cap has increased from $1.75B to $3.06B, an increase of 75.29%. That is a compound annual growth rate of 13.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2025 | 3.06B | 38.78% |
| Dec 31, 2024 | 2.21B | 184.18% |
| Dec 29, 2023 | 777.13M | 165.01% |
| Dec 30, 2022 | 293.25M | -71.03% |
| Dec 31, 2021 | 1.01B | -42.11% |
| May 28, 2021 | 1.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 742.79B |
| Johnson & Johnson | 459.51B |
| AbbVie | 401.31B |
| UnitedHealth Group | 325.92B |
| AstraZeneca | 262.55B |
| Novartis AG | 251.13B |
| Novo Nordisk | 248.67B |
| Abbott Laboratories | 223.60B |